The Trump administration has proposed restricting federal funding for puberty blockers, hormones, and surgeries for minors with gender dysphoria, citing concerns over irreversible harm and shifting the debate on youth gender care amid political and medical tensions.
The Trump administration has moved to bar Medicaid and the Children’s Health Insurance Programme from paying for puberty blockers, cross-sex hormones and surgery for minors diagnosed with gender dysphoria, a step the White House says is aimed at protecting children from what it sees as irreversible harm. The policy does not outlaw the procedures, but it cuts off federal reimbursement for them and is due to take effect on October 13, according to administration officials and the announcement from the Centres for Medicare and Medicaid Services.
Brian Christine, an assistant secretary at the Department of Health and Human Services and a urologist who also oversees public health offices and programmes, defended the change in comments to Fox News Digital. Christine said children with gender dysphoria should be directed towards mental health counselling and compassionate care rather than medical interventions that can permanently alter their bodies. He argued that the rise in diagnoses among minors is not easily explained by epidemiology and described the trend as social contagion, a claim that remains disputed by many clinicians and researchers.
In a statement on Tuesday, CMS administrator Mehmet Oz said the government was following the science, protecting children and saving taxpayer money by ending federal support for what the administration calls sex-rejecting procedures. HHS has separately said it is moving to bar hospitals from performing these interventions on children under 18 as a condition of participation in Medicare and Medicaid, and the department’s civil rights office has rescinded earlier guidance tied to gender identity and health privacy in support of President Donald Trump’s executive order on what he has called “biological truth”.
The policy has landed in the middle of a long-running and deeply polarised national debate over gender care for minors. KFF says 27 states have enacted restrictions on such treatment, while Axios reported that the administration’s new rule follows other efforts to reduce federal support for transition-related care. Medical organisations including the American Medical Association continue to support gender-affirming care as appropriate treatment for some young people with gender dysphoria, underscoring the widening split between the administration’s position and mainstream clinical practice.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
